NorthWest Biotherapeutics Inc (NWBO): Not sure what NWBO trial you are referen...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	45
Posts	4462
Boards Moderated	0
Alias Born	03/20/2015

CherryTree1

Re: exwannabe post# 689673

Wednesday, 05/08/2024 1:43:05 PM

Wednesday, May 08, 2024 1:43:05 PM

Not sure what NWBO trial you are referencing EX:

Both with single P3 failed for futility.

Does NWBO have some other P3 that failed for futility???
I am only aware of DCVAX-L Phase - 3 which didn't fail for any reason, here is a link to their paper.
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
A Phase 3 Prospective Externally Controlled Cohort Trial
Conclusions
This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statistically significant extension of overall survival in both nGBM and rGBM. Treatment with DCVax-L also had an excellent safety profile and noteworthy tails of long-term survival curves.

Bullish

Men who are occupied in the restoration of health to other men, by the joint exertion of skill and humanity, are above all the great of the earth. They even partake of divinity, since to preserve and renew is almost as noble as to create.